Favipiravir-induced fever in coronavirus disease 2019: A report of two cases

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases

Favipiravir, an antiviral agent, is undergoing clinical trials for treating novel coronavirus disease 2019 (COVID-19). Here, we report two cases of COVID-19 with favipiravir-induced fever. In both cases, pyrexia was observed following the administration of favipiravir despite improvements in symptom...

Full description

Bibliographic Details
Main Authors: Hiroyuki Takoi, Yuki Togashi, Daiki Fujimori, Haruki Kaizuka, Shunsuke Otsuki, Takuya Wada, Yoshikazu Takeuchi, Shinji Abe
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal of Infectious Diseases
Subjects:
Favipiravir
Drug fever
COVID-19
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220321664

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220321664

Similar Items